enVVeno Medical Corporation
NVNO
$0.39
-$0.01-1.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.89% | 34.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.50% | 23.60% | |||
| Operating Income | 15.50% | -23.60% | |||
| Income Before Tax | 32.19% | -48.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 32.19% | -48.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.19% | -48.66% | |||
| EBIT | 15.50% | -23.60% | |||
| EBITDA | 15.54% | -23.91% | |||
| EPS Basic | 31.53% | -48.62% | |||
| Normalized Basic EPS | 14.84% | -25.17% | |||
| EPS Diluted | 31.53% | -48.62% | |||
| Normalized Diluted EPS | 14.84% | -25.17% | |||
| Average Basic Shares Outstanding | -0.97% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.97% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||